PALI
PALISADE BIO, INC.
Company overview
- Market capitalization
- $261.41M
- Employees
- 14
- Latest publication
- 2026-09-29
About PALISADE BIO, INC.
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate includes PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn's disease. The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 500,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 4,000USD | 0USD |
| Research Development | 7,400,000USD | 6,397,000USD | 6,173,000USD | 1,394,000USD | 1,675,000USD | 950,000USD | 2,084,000USD | 2,137,000USD |
| Total Operating Expenses | 12,198,000USD | 10,748,000USD | 9,981,000USD | 2,922,000USD | 2,843,000USD | 2,310,000USD | 3,382,000USD | 3,593,000USD |
| Net Income | -10,574,000USD | -9,600,000USD | -8,899,000USD | -2,868,000USD | -2,784,000USD | -2,230,000USD | -3,344,000USD | -3,487,000USD |
| Selling General Administrative | — | 4,351,000USD | 3,808,000USD | 1,528,000USD | 1,168,000USD | 1,360,000USD | 1,298,000USD | 1,456,000USD |
| Operating Income | — | -10,748,000USD | -9,981,000USD | -2,922,000USD | -2,843,000USD | -2,310,000USD | -3,382,000USD | -3,593,000USD |
| Interest Expense | — | 1,000USD | 2,000USD | 5,000USD | 2,000USD | 1,000USD | 3,000USD | 6,000USD |
| Net Interest Income | — | -1,000USD | -2,000USD | -5,000USD | -2,000USD | -1,000USD | -3,000USD | -6,000USD |
| Income Before Tax | — | -9,600,000USD | -8,899,000USD | -2,868,000USD | -2,784,000USD | -2,230,000USD | -3,344,000USD | -3,487,000USD |
| Net Income From Continuing Ops | — | -9,600,000USD | -8,899,000USD | -2,868,000USD | -2,784,000USD | -2,230,000USD | -3,344,000USD | -3,487,000USD |
| Ebitda | — | -10,748,000USD | -10,185,000USD | -2,862,000USD | -2,781,000USD | -2,228,000USD | -3,382,000USD | -3,480,000USD |
| Reconciled Depreciation | — | 0USD | 0USD | 1,000USD | 1,000USD | 1,000USD | 0USD | 1,000USD |
| Total Other Income Expense Net | — | 1,148,000USD | 1,082,000USD | 54,000USD | 59,000USD | 80,000USD | 38,000USD | 106,000USD |
| Ebit | — | — | -10,182,000USD | -2,863,000USD | -2,782,000USD | -2,229,000USD | -3,338,000USD | -3,481,000USD |
| Depreciation And Amortization | — | — | -3,000USD | 1,000USD | 1,000USD | 1,000USD | -3,000USD | 1,000USD |
| Cost Of Revenue | — | — | — | — | 1,000USD | 1,000USD | 2,000USD | 1,000USD |
| Gross Profit | — | — | — | — | -1,000USD | -1,000USD | 2,000USD | -1,000USD |
| Source | 0001357459-26-000017Preliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 250,000USD | 250,000USD | 0USD | 13,520USD | 15,394USD | 260,000USD |
| Cost Of Revenue | 3,000USD | 3,000USD | 4,000USD | 167,000USD | 168,000USD | 146,000USD | — | -990,000USD |
| Gross Profit | -3,000USD | -3,000USD | 250,000USD | -167,000USD | -168,000USD | -146,000USD | 15,394USD | 1,250,000USD |
| Research Development | 10,192,000USD | 9,063,000USD | 6,893,000USD | 6,547,000USD | 2,430,000USD | 3,099,000USD | 4,061,000USD | 3,960,000USD |
| Selling General Administrative | 7,864,000USD | 5,796,000USD | 6,202,000USD | 8,764,000USD | 9,307,000USD | 6,198,000USD | 7,272,000USD | 3,566,000USD |
| Total Operating Expenses | 18,056,000USD | 14,859,000USD | 13,320,000USD | 15,721,000USD | 41,854,000USD | 9,151,000USD | 8,647,000USD | 8,519,000USD |
| Operating Income | -18,056,000USD | -14,859,000USD | -13,070,000USD | -15,721,000USD | -41,854,000USD | -9,297,000USD | -8,632,000USD | -8,259,000USD |
| Interest Expense | 10,000USD | 12,000USD | 15,000USD | 13,000USD | 2,398,000USD | 235,000USD | 8,920USD | 7,698USD |
| Net Interest Income | -10,000USD | -12,000USD | -15,000USD | -13,000USD | -3,084,000USD | -1,076,000USD | — | — |
| Income Before Tax | -16,781,000USD | -14,438,000USD | -12,300,000USD | -14,260,000USD | -26,616,000USD | -10,322,000USD | -8,352,000USD | -4,925,000USD |
| Net Income | -16,781,000USD | -14,438,000USD | -12,300,000USD | -14,260,000USD | -26,616,000USD | -10,322,000USD | -8,352,000USD | -4,925,000USD |
| Net Income From Continuing Ops | -16,781,000USD | -14,438,000USD | -12,300,000USD | -14,260,000USD | -26,616,000USD | -10,322,000USD | — | — |
| Ebit | -16,771,000USD | -14,426,000USD | -12,285,000USD | -14,247,000USD | -24,218,000USD | -10,087,000USD | -8,342,859USD | -4,916,803USD |
| Ebitda | -16,768,000USD | -14,423,000USD | -12,281,000USD | -14,244,000USD | -24,216,000USD | -9,941,000USD | -8,199,000USD | -4,731,000USD |
| Depreciation And Amortization | 3,000USD | 3,000USD | 4,000USD | 3,000USD | 2,000USD | 146,000USD | 143,859USD | 185,803USD |
| Reconciled Depreciation | 3,000USD | 3,000USD | 4,000USD | 3,000USD | 2,000USD | 3,000USD | — | — |
| Total Other Income Expense Net | 1,275,000USD | 421,000USD | 770,000USD | 1,461,000USD | 15,238,000USD | -1,025,000USD | 280,043USD | 3,335,000USD |
| Selling And Marketing Expenses | — | — | 4,000USD | — | — | — | — | 807,462USD |
| Income Tax Expense | — | — | 16,000USD | -1,461,000USD | 655,000USD | 248,000USD | 288,963USD | 3,343,000USD |
| Net Income Applicable To Common Shares | — | — | — | -14,548,000USD | -26,616,000USD | -10,322,000USD | -10,064,000USD | -4,484,000USD |
| Unclassified Operating Expenses | — | — | — | — | 30,117,000USD | — | -2,686,000USD | — |
| Interest Income | — | — | — | — | — | 28,810USD | 557,950USD | 3,340,230USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 127,315,000USD | 133,315,000USD | 134,344,000USD | 6,973,000USD | 6,667,000USD | 8,190,000USD | 10,880,000USD | 9,336,000USD |
| Cash And Equivalents | 125,172,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 127,260,000USD | 133,243,000USD | 134,221,000USD | 6,828,000USD | 6,447,000USD | 7,887,000USD | 10,494,000USD | 8,870,000USD |
| Total Liabilities | 5,567,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,246,000USD | 5,620,000USD | 4,636,000USD | 3,478,000USD | 3,970,000USD | 2,777,000USD | 3,236,000USD | 2,681,000USD |
| Total Stockholder Equity | 121,748,000USD | 127,362,000USD | 129,380,000USD | 3,212,000USD | 2,620,000USD | 5,331,000USD | 7,492,000USD | 6,608,000USD |
| Total Equity Including Noncontrolling Interest | 121,748,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 71,000USD | — | 71,000USD | 211,000USD | 314,000USD | — | 79,000USD | 235,000USD |
| Net Receivables | 500,000USD | 9,000USD | 264,000USD | 18,000USD | 6,000USD | 78,000USD | 24,000USD | 96,000USD |
| Other Current Assets | — | 606,000USD | 572,000USD | 1,583,000USD | 1,024,000USD | 579,000USD | 649,000USD | 830,000USD |
| Total Liab | — | 5,953,000USD | 4,964,000USD | 3,761,000USD | 4,047,000USD | 2,859,000USD | 3,388,000USD | 2,728,000USD |
| Other Current Liab | — | 2,924,000USD | 3,798,000USD | 1,841,000USD | 1,847,000USD | 1,777,000USD | 1,853,000USD | 1,958,000USD |
| Common Stock | — | 1,674,000USD | 1,594,000USD | 91,000USD | 48,000USD | 43,000USD | 27,000USD | 11,000USD |
| Capital Stock | — | 1,676,000USD | 1,596,000USD | 93,000USD | 50,000USD | 45,000USD | 29,000USD | 13,000USD |
| Retained Earnings | — | -162,325,000USD | -152,725,000USD | -143,826,000USD | -140,958,000USD | -138,174,000USD | -135,944,000USD | -132,600,000USD |
| Cash | — | 132,628,000USD | 133,385,000USD | 5,227,000USD | 5,417,000USD | 7,230,000USD | 9,821,000USD | 8,040,000USD |
| Cash And Short Term Investments | — | 132,628,000USD | 133,385,000USD | 5,227,000USD | 5,417,000USD | 7,230,000USD | 9,821,000USD | 8,040,000USD |
| Net Debt | — | -132,628,000USD | -133,314,000USD | -5,016,000USD | -5,079,000USD | -7,172,000USD | -9,652,000USD | -7,683,000USD |
| Accounts Payable | — | 2,696,000USD | 767,000USD | 1,426,000USD | 1,785,000USD | 942,000USD | 1,214,000USD | 366,000USD |
| Common Stock Shares Outstanding | — | 209,663,966shares | 55,669,821shares | 7,473,898shares | 4,797,196shares | 4,796,000shares | 8,540,000shares | 5,818,000shares |
| Non Current Assets Total | — | 72,000USD | 123,000USD | 145,000USD | 220,000USD | 303,000USD | 386,000USD | 466,000USD |
| Non Current Liabilities Total | — | 333,000USD | 328,000USD | 283,000USD | 77,000USD | 82,000USD | 152,000USD | 47,000USD |
| Non Current Liabilities Other | — | 271,000USD | 266,000USD | 283,000USD | 75,000USD | 80,000USD | 150,000USD | 47,000USD |
| Non Currrent Assets Other | — | 17,000USD | 68,000USD | 119,000USD | 197,000USD | 222,000USD | 273,000USD | 324,000USD |
| Net Working Capital | — | 127,623,000USD | 129,585,000USD | 3,350,000USD | 2,477,000USD | 5,110,000USD | 7,258,000USD | 6,189,000USD |
| Unclassified Equity | — | 286,337,000USD | 278,915,000USD | 146,854,000USD | 143,480,000USD | 143,417,000USD | 143,380,000USD | 139,184,000USD |
| Short Term Debt | — | — | 71,000USD | 211,000USD | 338,000USD | 58,000USD | 169,000USD | 357,000USD |
| Short Long Term Debt Total | — | — | 71,000USD | 211,000USD | 338,000USD | 58,000USD | 169,000USD | 357,000USD |
| Property Plant Equipment Net | — | — | 0USD | 0USD | 23,000USD | 55,000USD | 87,000USD | 116,000USD |
| Property Plant Equipment Gross | — | — | 0USD | 0USD | 23,000USD | 55,000USD | 87,000USD | 116,000USD |
| Inventory | — | — | — | — | — | — | — | -96,000USD |
| Source | 0001357459-26-000017Preliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 134,344,000USD | 10,880,000USD | 14,052,000USD | 15,763,000USD | 12,512,000USD | 3,019,000USD | 6,583,889USD | 7,684,450USD |
| Other Current Assets | 572,000USD | 649,000USD | 748,000USD | 912,000USD | 861,000USD | 167,000USD | 510,900USD | 363,288USD |
| Total Liab | 4,964,000USD | 3,388,000USD | 2,739,000USD | 3,284,000USD | 5,147,000USD | 10,118,000USD | 1,457,896USD | 1,634,900USD |
| Total Stockholder Equity | 129,380,000USD | 7,492,000USD | 11,313,000USD | 12,479,000USD | 7,365,000USD | -7,099,000USD | 5,125,993USD | 6,049,550USD |
| Other Current Liab | 3,798,000USD | 1,962,000USD | 1,609,000USD | 1,060,000USD | 779,000USD | 4,330,000USD | 260,351USD | 218,602USD |
| Common Stock | 1,594,000USD | 27,000USD | 93,000USD | 30,000USD | 3,000USD | 28,000USD | 38,665USD | 182,051USD |
| Capital Stock | 1,596,000USD | 29,000USD | 95,000USD | 32,000USD | 145,000USD | 28,000USD | — | — |
| Retained Earnings | -152,725,000USD | -135,944,000USD | -121,506,000USD | -109,190,000USD | -94,642,000USD | -68,026,000USD | -221,975,544USD | -213,623,893USD |
| Cash | 133,385,000USD | 9,821,000USD | 12,432,000USD | 12,383,000USD | 10,495,000USD | 713,000USD | 5,114,917USD | 5,787,110USD |
| Cash And Short Term Investments | 133,385,000USD | 9,821,000USD | 12,432,000USD | 12,383,000USD | 10,495,000USD | 729,000USD | 5,114,917USD | 5,787,110USD |
| Total Current Assets | 134,221,000USD | 10,494,000USD | 13,328,000USD | 14,733,000USD | 11,506,000USD | 896,000USD | 5,646,881USD | 6,508,393USD |
| Total Current Liabilities | 4,636,000USD | 3,236,000USD | 2,586,000USD | 3,012,000USD | 2,496,000USD | 8,082,000USD | 1,224,757USD | 1,051,166USD |
| Net Debt | -133,314,000USD | -9,652,000USD | -12,063,000USD | -11,979,000USD | -10,296,000USD | 708,000USD | -4,826,374USD | -749,110USD |
| Short Term Debt | 71,000USD | 169,000USD | 279,000USD | 193,000USD | 199,000USD | 1,215,000USD | 140,000USD | — |
| Short Long Term Debt | 71,000USD | 79,000USD | 158,000USD | 88,000USD | 87,000USD | 1,047,000USD | — | — |
| Short Long Term Debt Total | 71,000USD | 169,000USD | 369,000USD | 404,000USD | 199,000USD | 1,421,000USD | 288,543USD | 5,038,000USD |
| Net Receivables | 264,000USD | 24,000USD | 148,000USD | 1,438,000USD | 150,000USD | 59,000USD | 21,064USD | 357,995USD |
| Accounts Payable | 767,000USD | 1,105,000USD | 698,000USD | 1,759,000USD | 1,518,000USD | 2,537,000USD | 824,406USD | 832,564USD |
| Property Plant Equipment Net | 0USD | 87,000USD | 208,000USD | 310,000USD | 112,000USD | 280,000USD | 242,736USD | 90,311USD |
| Property Plant Equipment Gross | 0USD | 87,000USD | 208,000USD | 310,000USD | 112,000USD | 10,776USD | 268,072USD | 90,311USD |
| Common Stock Shares Outstanding | 55,669,821shares | 1,416,000shares | 456,014shares | 880,305shares | 12,463shares | 237,390shares | 237,390shares | 273,240shares |
| Non Current Assets Total | 123,000USD | 386,000USD | 724,000USD | 1,030,000USD | 1,006,000USD | 2,123,000USD | 937,008USD | 1,176,057USD |
| Non Current Liabilities Total | 328,000USD | 152,000USD | 153,000USD | 272,000USD | 2,651,000USD | 2,036,000USD | 233,138USD | 583,734USD |
| Non Current Liabilities Other | 266,000USD | 150,000USD | 63,000USD | 61,000USD | 2,651,000USD | 1,830,000USD | — | — |
| Non Currrent Assets Other | 68,000USD | 273,000USD | 516,000USD | 694,000USD | 894,000USD | 1,843,000USD | 25,336USD | 23,965USD |
| Net Working Capital | 129,585,000USD | 7,258,000USD | 10,742,000USD | 11,721,000USD | 9,878,000USD | -7,186,000USD | — | — |
| Unclassified Equity | 278,915,000USD | 143,380,000USD | 132,631,000USD | 121,607,000USD | 101,859,000USD | 60,871,734USD | 227,069,058USD | 219,491,805USD |
| Inventory | — | 12,000USD | — | -1,438,000USD | -150,000USD | -2,227,552USD | — | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | — | -734USD | -6,186USD | -413USD |
| Other Liab | — | — | — | — | 2,651,000USD | 1,830,000USD | — | 176,000USD |
| Other Assets | — | — | — | — | 26,000USD | 157,572USD | 26,000USD | 0USD |
| Net Tangible Assets | — | — | — | — | 7,363,000USD | -16,602,000USD | -8,332,000USD | -45,198,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | -2,651,000USD | -3,535,000USD | — | — |
| Intangible Assets | — | — | — | — | — | 147,130USD | 668,936USD | 763,543USD |
| Deferred Long Term Liab | — | — | — | — | — | 1,817,000USD | — | — |
| Long Term Debt | — | — | — | — | — | 94,000USD | — | — |
| Short Term Investments | — | — | — | — | — | 16,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | — | -1,047,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | -4,503,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -9,600,000USD | -8,899,000USD | -2,868,000USD | -2,784,000USD | -2,230,000USD | -3,344,000USD | -3,487,000USD | -4,080,000USD |
| Depreciation | 0USD | 0USD | 1,000USD | 1,000USD | 1,000USD | 0USD | 1,000USD | 1,000USD |
| Stock Based Compensation | 4,297,000USD | 3,727,000USD | 90,000USD | 69,000USD | 69,000USD | 77,000USD | 95,000USD | 362,000USD |
| Other Non Cash Items | 4,302,000USD | -84,000USD | 293,000USD | 98,000USD | 30,000USD | 145,000USD | -84,000USD | 106,000USD |
| Change In Working Capital | 1,408,000USD | 2,112,000USD | -1,069,000USD | 799,000USD | -203,000USD | 741,000USD | 342,000USD | 112,000USD |
| Total Cash From Operating Activities | -3,890,000USD | -3,144,000USD | -3,553,000USD | -1,817,000USD | -2,333,000USD | -2,381,000USD | -3,133,000USD | -3,499,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,890,000USD | -3,144,000USD | -3,553,000USD | -1,817,000USD | -2,333,000USD | -2,381,000USD | -3,133,000USD | -3,499,000USD |
| Net Borrowings | -71,000USD | -140,000USD | -100,000USD | 0USD | -80,000USD | -156,000USD | -112,000USD | — |
| Total Cash From Financing Activities | 3,133,000USD | 131,331,000USD | 3,363,000USD | 4,000USD | -258,000USD | 4,162,000USD | -180,000USD | 3,576,000USD |
| Issuance Of Capital Stock | 3,250,000USD | 128,219,000USD | 0USD | 0USD | 0USD | 4,435,000USD | 0USD | 4,000,000USD |
| Change In Cash | -757,000USD | 128,187,000USD | -190,000USD | -1,813,000USD | -2,591,000USD | 1,781,001USD | -3,313,000USD | 77,000USD |
| Begin Period Cash Flow | 133,384,999USD | 5,253,000USD | 5,417,000USD | 7,256,000USD | 9,847,000USD | 8,039,999USD | 11,379,000USD | 11,276,000USD |
| End Period Cash Flow | 132,627,999USD | 133,440,000USD | 5,227,000USD | 5,443,000USD | 7,256,000USD | 9,821,000USD | 8,066,000USD | 11,353,000USD |
| Other Cashflows From Financing Activities | 3,133,000USD | -49,999USD | -445,000USD | 4,000USD | -258,000USD | 8,318,000USD | -68,000USD | -424,000USD |
| Unclassified Operating Cash Flow | -4,297,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -3,179,000USD | 131,504,999USD | 3,908,000USD | — | — | -4,011,000USD | — | 3,989,000USD |
| Sale Purchase Of Stock | — | 16,000USD | — | 3,000USD | — | 11,000USD | — | 11,000USD |
| Investments | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -16,781,000USD | -14,438,000USD | -12,300,000USD | -14,260,000USD | -26,616,000USD | -10,322,000USD | -8,351,651USD | -4,924,617USD |
| Depreciation | 3,000USD | 3,000USD | 4,000USD | 3,000USD | 2,000USD | 3,000USD | 143,859USD | 185,803USD |
| Stock Based Compensation | 3,955,000USD | 652,000USD | 624,000USD | 1,032,000USD | 1,891,000USD | 2,014,000USD | 3,325,000USD | 1,090,000USD |
| Other Non Cash Items | 337,000USD | 199,000USD | 139,000USD | -1,385,000USD | 14,706,000USD | 1,186,000USD | 743,827USD | -2,288,936USD |
| Change In Working Capital | 1,639,000USD | 1,391,000USD | 400,000USD | 1,250,000USD | -4,756,000USD | 2,389,000USD | 208,285USD | -336,881USD |
| Total Cash From Operating Activities | -10,847,000USD | -12,193,000USD | -11,133,000USD | -13,360,000USD | -14,773,000USD | -4,768,000USD | -7,255,680USD | -7,692,419USD |
| Capital Expenditures | 0USD | 0USD | -4,000USD | -10,000USD | 0USD | -6,000USD | -6,000USD | -1,714USD |
| Free Cash Flow | -10,847,000USD | -12,193,000USD | -11,137,000USD | -13,370,000USD | -14,773,000USD | -4,774,000USD | -7,255,680USD | -7,694,133USD |
| Net Borrowings | -320,000USD | -426,000USD | -391,000USD | -790,000USD | -183,000USD | 1,977,000USD | -220,000USD | 1,357,000USD |
| Total Cash From Financing Activities | 134,440,000USD | 9,582,000USD | 11,186,000USD | 15,258,000USD | 24,609,000USD | 1,890,000USD | 6,589,505USD | 1,814,233USD |
| Sale Purchase Of Stock | 19,000USD | 11,000USD | 17,000USD | — | -99,000USD | 14,698,210USD | 6,553,080USD | 1,828,000USD |
| Issuance Of Capital Stock | 128,219,000USD | 8,435,000USD | 9,419,000USD | 14,401,000USD | 25,109,000USD | 1,175,000USD | — | — |
| Change In Cash | 123,593,000USD | -2,611,000USD | 49,000USD | 1,888,000USD | 9,782,000USD | -2,884,000USD | -672,193USD | -887,830USD |
| Begin Period Cash Flow | 9,847,000USD | 12,458,000USD | 12,409,000USD | 10,521,000USD | 739,000USD | 3,623,000USD | 5,787,110USD | 6,674,940USD |
| End Period Cash Flow | 133,440,000USD | 9,847,000USD | 12,458,000USD | 12,409,000USD | 10,521,000USD | 739,000USD | 5,114,917USD | 5,787,110USD |
| Other Cashflows From Financing Activities | -495,000USD | 1,573,000USD | 2,158,000USD | 1,647,000USD | 19,583,000USD | -87,000USD | 6,553,078USD | 207,000USD |
| Unclassified Financing Cash Flow | 135,236,000USD | 8,424,000USD | 9,402,000USD | — | 5,407,000USD | -14,698,210USD | -6,296,653USD | -1,577,767USD |
| Investments | — | 0USD | -4,000USD | -10,000USD | -54,000USD | -6,000USD | — | — |
| Total Cashflows From Investing Activities | — | — | -4,000USD | -10,000USD | -54,000USD | -6,000USD | 3,921,193USD | 4,998,286USD |
| Change To Account Receivables | — | — | — | — | 84,000USD | -59,000USD | 272,993USD | 80,809USD |
| Change To Inventory | — | — | — | — | -84,000USD | -947,000USD | 15,741USD | 36,991USD |
| Change To Liabilities | — | — | — | — | -2,395,000USD | 1,006,000USD | 836,000USD | 86,000USD |
| Dividends Paid | — | — | — | — | -99,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | -54,000USD | — | — | 5,000,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -3,325,000USD | -1,417,788USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 3,927,193USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.